From: Effect of a family and interdisciplinary intervention to prevent T2D: randomized clinical trial
Anthropometric Characteristics | Individual Group (n = 33) | Familiar Group (n = 68) | ||||
---|---|---|---|---|---|---|
Basal (n = 33) | Month 6 (n = 13) | Month 12 (n = 7) | Basal (n = 68) | Month 6 (n = 36) | Month 12 (n = 23) | |
Weight (kg) | 72.0 ± 17.0 | 66.4 ± 16.0 | 75.0 ± 16.0C | 68.6 ± 17.0 | 68.5 ± 16.0 | 65.4 ± 16.8 |
BMI (kg/m2) | 26.3 ± 5.4 | 25.0 ± 5.4 | 28.4 ± 5.2C | 25.9 ± 5.2 | 26.3 ± 5.3 | 25.5 ± 5.3 |
WC (cm) | 86.0 ± 12.6 | 82.6 ± 11.8B | 88.7 ± 11.2 | 83.6 ± 17.2 | 83.9 ± 11.8 | 78.8 ± 17.3 |
Body fat (%) | 29.0 ± 11.0 | 28.2 ± 11.7 | 30.8 ± 13.0C | 28.3 ± 9.0 | 28.6 ± 10.1 | 28.9 ± 10.1 |
Visceral Index (AU) | 5.5 ± 4.0 | 4.7 ± 3.3 | 5.4 ± 3.9 | 6.3 ± 4.6 | 6.4 ± 4.6 | 5.0 ± 3.7 |
SBP (mm Hg) | 108 ± 10 | 109 ± 10 | 111 ± 7 | 108 ± 14 | 110 ± 10 | 111 ± 13 |
Biochemistry Characteristics | ||||||
Glucose (mg/dl) 0 min | 89 ± 8.0 | 91 ± 10 | 88 ± 7 | 92 ± 9.0 | 90 ± 10 | 93 ± 10 |
Glucose (mg/dl) 120 min | 106 ± 22 | Not done | 104 ± 29 | 102 ± 19 | Not done | 100 ± 22 |
AUCgluc_OGTT (mg/dl/min) | 14,262 ± 2342 | Not done | 14,556 ± 2410 | 13,691 ± 2534 | Not done | 13,966 ± 2679 |
Tg (mg/dl) | 103 ± 38 | 118 ± 36 | 108 ± 40 | 123 ± 58 | 128 ± 65 | 112 ± 62 |
Total Cholesterol (mg/dl) | 167 ± 29 | 161 ± 30 | 180 ± 39∆I | 174 ± 38 | 167 ± 38 | 159 ± 30∆I |
HDL (mg/dl) | 45 ± 11 | 50 ± 14 | 46 ± 12 | 44 ± 12 | 43 ± 11 | 50 ± 11 |
LDL (mg/dl) | 102 ± 28 | 87 ± 28 | 112 ± 38C, ∆I | 104 ± 32 | 102 ± 30E | 90 ± 29F, ∆I |
Markers of insulin resistance and B cell function | ||||||
Matsuda Index | 6.3 ± 3.9 | Not done | 4.6 ± 3.5 | 5.2 ± 3.2 | Not done | 5.5 ± 2.6 |
HOMA IR | 1.8 ± 0.9 | Not done | 2.4 ± 1.0 | 2.3 ± 1.4 | Not done | 2.4 ± 1.8 |
Insulin secretion | 0.47 ± 0.25 A | Not done | 0.75 ± 0.38 | 0.66 ± 0.35 A | Not done | 0.60 ± 0.33 |
Disposition Index | 2.38 ± 0.75 | Not done | 2.64 ± 0.55 | 2.68 ± 0.86 | Not done | 2.62 ± 0.87 |